The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity
Open accessAbstract
Inorganic pyrophosphate (PP(i)) produced by cells inhibits mineralization by binding to crystals. Its ubiquitous presence is thought to prevent "soft" tissues from mineralizing, whereas its degradation to P(i) in bones and teeth by tissue-nonspecific alkaline phosphatase (Tnap, Tnsalp, Alpl, Akp2) may facilitate crystal growth. Whereas the crystal binding properties of PP(i) are largely understood, less is known about its effects on osteoblast activity. We have used MC3T3-E1 osteoblast cultures to investigate the effect of PP(i) on osteoblast function and matrix mineralization. Mineralization in the cultures was dose-dependently inhibited by PP(i). This inhibition could be reversed by Tnap, but not if PP(i) was bound to mineral. PP(i) also led to increased levels of osteopontin (Opn) induced via the Erk1/2 and p38 MAPK signaling pathways. Opn regulation by PP(i) was also insensitive to foscarnet (an inhibitor of phosphate uptake) and levamisole (an inhibitor of Tnap enzymatic activity), suggesting that increased Opn levels did not result from changes in phosphate. Exogenous OPN inhibited mineralization, but dephosphorylation by Tnap reversed this effect, suggesting that OPN inhibits mineralization via its negatively charged phosphate residues and that like PP(i), hydrolysis by Tnap reduces its mineral inhibiting potency. Using enzyme kinetic studies, we have shown that PP(i) inhibits Tnap-mediated P(i) release from beta-glycerophosphate (a commonly used source of organic phosphate for culture mineralization studies) through a mixed type of inhibition. In summary, PP(i) prevents mineralization in MC3T3-E1 osteoblast cultures by at least three different mechanisms that include direct binding to growing crystals, induction of Opn expression, and inhibition of Tnap activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The determination of enzyme inhibitor constants
Dixon, M. (1953) · Biochemical Journal · doi:10.1042/bj0550170 · Cited by 4,069
Sodek, J., Ganss, B., & McKee, M. D. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110030101 · Cited by 993
Self-citationCornish-Bowden, A. (1974) · Biochemical Journal · doi:10.1042/bj1370143 · Cited by 935
Hessle, L., Johnson, K. A., Anderson, H. C., Narisawa, S., Sali, A., Goding, J. W., Terkeltaub, R., & Millán, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142063399 · Cited by 864
Mineralized bone nodules formedin vitro from enzymatically released rat calvaria cell populations
Bellows, C. G., Aubin, J. E., Heersche, J. N. M., & Antosz, M. E. (1986) · Calcified Tissue International · doi:10.1007/bf02556874 · Cited by 846
Wang, D., Christensen, K., Chawla, K., Xiao, G., Krebsbach, P. H., & Dr. Franceschi, R. T. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.893 · Cited by 664
Role of the Mouse ank Gene in Control of Tissue Calcification and Arthritis
Ho, A. M., Johnson, M. D., & Kingsley, D. M. (2000) · Science · doi:10.1126/science.289.5477.265 · Cited by 652
Murshed, M., Harmey, D., Millán, J. L., McKee, M. D., & Karsenty, G. (2005) · Genes & Development · doi:10.1101/gad.1276205 · Cited by 601
Self-citationMAPK Pathways Activate and Phosphorylate the Osteoblast-specific Transcription Factor, Cbfa1
Xiao, G., Jiang, D., Thomas, P., Benson, M. D., Guan, K., Karsenty, G., & Franceschi, R. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4453 · Cited by 552
Hypophosphatasia and the Role of Alkaline Phosphatase in Skeletal Mineralization*
WHYTE, M. P. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-4-439 · Cited by 536
Cited by
The role of alkaline phosphatase in mineralization
Golub, E. E., & Boesze-Battaglia, K. (2007) · Current Opinion in Orthopaedics · doi:10.1097/bco.0b013e3282630851 · Cited by 826
Review: biologically active pyrazole derivatives
Ansari, A., Ali, A., Asif, M., & Shamsuzzaman, S. (2017) · New Journal of Chemistry · doi:10.1039/c6nj03181a · Cited by 786
Cellular mechanisms of cadmium-induced toxicity: a review
Rani, A., Kumar, A., Lal, A., & Pant, M. (2014) · International Journal of Environmental Health Research · doi:10.1080/09603123.2013.835032 · Cited by 719
The Mechanism of Mineralization and the Role of Alkaline Phosphatase in Health and Disease
Orimo, H. (2010) · Journal of Nippon Medical School · doi:10.1272/jnms.77.4 · Cited by 718
Demineralization–remineralization dynamics in teeth and bone
Abou Neel, E., Aljabo, A., Strange, A., Ibrahim, S., Coathup, M., Young, A., Bozec, L., & Mudera, V. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s107624 · Cited by 697
miR-214 targets ATF4 to inhibit bone formation
Wang, X., Guo, B., Li, Q., Peng, J., Yang, Z., Wang, A., Li, D., Hou, Z., Lv, K., Kan, G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3026 · Cited by 559
Bioinorganics and biomaterials: Bone repair
Habibovic, P., & Barralet, J. E. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.03.027 · Cited by 441
The roles of ions on bone regeneration
O’Neill, E., Awale, G., Daneshmandi, L., Umerah, O., & Lo, K. W.-H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.049 · Cited by 441
Role of matrix vesicles in biomineralization
Golub, E. E. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.09.006 · Cited by 393
Hoemann, C. D., El-Gabalawy, H., & McKee, M. D. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2008.06.004 · Cited by 335
Self-citationShroff, R. C., McNair, R., Skepper, J. N., Figg, N., Schurgers, L. J., Deanfield, J., Rees, L., & Shanahan, C. M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060640 · Cited by 314
Osteopontin in Bone Metabolism and Bone Diseases
Si, J., Wang, C., Zhang, D., Wang, B., Hou, W., & Zhou, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.919159 · Cited by 301
Lakhkar, N. J., Lee, I.-H., Kim, H.-W., Salih, V., Wall, I. B., & Knowles, J. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.05.015 · Cited by 280
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Beck-Nielsen, S. S., Mughal, Z., Haffner, D., Nilsson, O., Levtchenko, E., Ariceta, G., de Lucas Collantes, C., Schnabel, D., Jandhyala, R., & Mäkitie, O. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1014-8 · Cited by 278
Addison, W. N., Nakano, Y., Loisel, T., Crine, P., & McKee, M. D. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080601 · Cited by 214
Self-citationPyrophosphate: a key inhibitor of mineralisation
Orriss, I. R., Arnett, T. R., & Russell, R. G. G. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.03.003 · Cited by 181
“Earlier work indicated that, in the presence of a second substrate such as β-glycerophosphate, pyrophosphate can cause a conformational change in TNAP which inhibits the enzyme thereby reducing pyrophosphate hydrolysis [102] .”
BackgroundFournier, C., Rizzoli, R., & Ammann, P. (2014) · Endocrinology · doi:10.1210/en.2014-1308 · Cited by 15
Osteogenic Effects of Ion Released from Biodegradable Metallic Magnesium and Calcium Coating
Miyake, R., Shimabukuro, M., Terauchi, M., Marukawa, E., & Kawashita, M. (2025) · Advanced Biology · doi:10.1002/adbi.202500401 · Cited by 5
Metadata
- Authors
- Addison, W. N., Azari, F., Sørensen, E. S., Kaartinen, M. T., & McKee, M. D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 282
- Issue
- 21
- Pages
- 15872-15883
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2038994554
- Cited by
- 403
- References
- 55
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.